본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Myelomeningocele: The Evolution of Care over the last 50 years Wang Kyu Chang
(Department of Neurosurgery)


()
. Myelomeningocele: The Evolution of Care over the last 50 years. CHILDS NERVOUS SYSTEM. 2023-07-07; 2023; 39(10):2829~2845. IF 1.4 (2022)
Is Fragmented Cancer Care Associated With Medical Expenditures? Nationwide Evidence From Patients With Lung Cancer Using National Insurance Claim Data
()

Han Kyu Tae
(Division of Cancer Management Policy)
. Is Fragmented Cancer Care Associated With Medical Expenditures? Nationwide Evidence From Patients With Lung Cancer Using National Insurance Claim Data. INTERNATIONAL JOURNAL OF PUBLIC HEALTH. 2023-07-06; 2023; 68:1606000~. IF 4.6 (2022)
Current Status and Physicians’ Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/Oncologists Park Hyeon Jin
(Department of Pediatrics)


()
. Current Status and Physicians’ Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/Oncologists. JOURNAL OF KOREAN MEDICAL SCIENCE. 2023-07-05; 2023; 38(29):e230~. IF 4.5 (2022)
Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study LEE, BYUNG IL
(Targeted Therapy Branch)


(Department of Cancer Biomedical Science)
. Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study. SCIENTIFIC REPORTS. 2023-07-04; 2023; 13(1):10805~. IF 4.6 (2022)
NR1D1 stimulates antitumor immune responses in breast cancer by activating cGAS-STING signaling Lee Ho
(Department of Cancer Biomedical Science)

Park Mi Kyung
(Department of Cancer Biomedical Science)
. NR1D1 stimulates antitumor immune responses in breast cancer by activating cGAS-STING signaling. CANCER RESEARCH. 2023-07-03; 2023; 83(18):3045~3058. IF 11.2 (2022)
Feature Importance Analysis of a Deep Learning Model for Predicting Late Bladder Toxicity Occurrence in Uterine Cervical Cancer Patients Kim Haksoo
(Department of Radiation oncology)

Cheon Won Joong
(Center for Proton Therapy)
. Feature Importance Analysis of a Deep Learning Model for Predicting Late Bladder Toxicity Occurrence in Uterine Cervical Cancer Patients. CANCERS. 2023-07-02; 2023; 15(13):3463~. IF 5.2 (2022)
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) Hyeon-Seok Eom
(Hospital)


()
. Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015). ANNALS OF HEMATOLOGY. 2023-07-01; 2023; 102(8):2233~2240. IF 3.5 (2022)
Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association_(CMH) Lee, In Joon
(Interventional Medicine Branch)

Cho Yu Ri
(Center for Liver and Pancreatobiliary Cancer )
. Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association_(CMH). CLINICAL AND MOLECULAR HEPATOLOGY. 2023-07-01; 2023; 29(3):521~541. IF 8.9 (2022)
Annotation-Efficient Deep Learning Model for Pancreatic Cancer Diagnosis and Classification Using CT Images: A Retrospective Diagnostic Study Woo Sang Myung
(Immuno-oncology Branch)

Chun Jung Won
(Interventional Medicine Branch)
. Annotation-Efficient Deep Learning Model for Pancreatic Cancer Diagnosis and Classification Using CT Images: A Retrospective Diagnostic Study. CANCERS. 2023-06-28; 2023; 15(13):3392~. IF 5.2 (2022)
Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R) LIM MYONG CHEOL
(Center for Uterine Cancer)


()
. Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R). JOURNAL OF GYNECOLOGIC ONCOLOGY. 2023-06-27; 2023; 34:e72~. IF 3.9 (2022)